CoChat

Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

Open access

The DOI matches its Crossref record; 159 of the 161 references it cites were found in a registry or an index.

Abstract

HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use disorders negatively affect the health of HIV-infected drug users, who also have frequent medical and psychiatric comorbidities that complicate HIV treatment and prevention. Evidence-based treatments are available for the management of substance-use disorders, mental illness, HIV and other infectious complications such as viral hepatitis and tuberculosis, and many non-HIV-associated comorbidities. Tuberculosis co-infection in HIV-infected drug users, including disease caused by drug-resistant strains, is acquired and transmitted as a consequence of inadequate prescription of antiretroviral therapy, poor adherence, and repeated interfaces with congregate settings such as prisons. Medication-assisted therapies provide the strongest evidence for HIV treatment and prevention efforts, yet are often not available where they are needed most. Antiretroviral therapy, when prescribed and adherence is at an optimum, improves health-related outcomes for HIV infection and many of its comorbidities, including tuberculosis, viral hepatitis, and renal and cardiovascular disease. Simultaneous clinical management of multiple comorbidities in HIV-infected drug users might result in complex pharmacokinetic drug interactions that must be adequately addressed. Moreover, interventions to improve adherence to treatment, including integration of health services delivery, are needed. Multifaceted, interdisciplinary approaches are urgently needed to achieve parity in health outcomes in HIV-infected drug users.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)60829-x

Cites

159 of 159 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 159 references

Research works printed but not linked: 4

  1. Lewden C, Mortality Working Group of COHERE. Time with CD4 cell count above 500 cells/mm3 allows HIV-infected men, but not women, to reach similar mortality rates to those of the general population: a seven-year analysis. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA, USA; Feb 16–19, 2010. Abstract 527.
  2. Lobmaier, 2008, Sustained-release naltrexone for opioid dependence, Cochrane Database Syst Rev, 2
  3. Samandari T, Mosimaneotsile B, Agizew T, et al. Randomized, placebo-controlled trial of 6 vs 36 months isoniazid TB preventive therapy for HIV-infected adults in Botswana. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA, USA; Feb 16–19, 2010. Abstract 104LB.
  4. Arnsten JH, Berg KM, Mouriz J, Li X, Goldberg U, Goldstein H. Final results from a 6-month, randomized controlled trial of directly observed therapy delivered in methadone clinics. Fourth International Conference on HIV Treatment Adherence; Miami, FL, USA; April 5–7, 2009. Abstract 030.

Cited by

See all 545

Metadata

Authors
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H.
Affiliations
  • Yale University (US)
  • University of Malaya (MY)
  • Instituto de Salud Carlos III (ES)
  • Universidade Federal do Rio de Janeiro (BR)
Corresponding author
Altice, Frederick L
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-07
Volume
376
Issue
9738
Pages
367-387
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2001592123
Cited by
504
References
161
Citations by year
2026: 11 · 2025: 17 · 2024: 27 · 2023: 20 · 2022: 15 · 2021: 34 · 2020: 31 · 2019: 25 · 2018: 38 · 2017: 45 · 2016: 40 · 2015: 42 · 2014: 35 · 2013: 54 · 2012: 36
FWCI
4.46
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Drug Abuse (R01DA025932, K24DA017072, R01DA025943, R01DA017059, R01DA013805)
Topics
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV, drug users, substance use disorders, psychiatric comorbidity, comorbidities, tuberculosis co-infection, drug-resistant tuberculosis, viral hepatitis, antiretroviral therapy, medication adherence, medication-assisted treatment, pharmacokinetic interactions, integrated care, HIV prevention
MeSH terms
Antitubercular Agents, Antiviral Agents, Bacterial Infections, Mental Disorders, Criminal Law, Drug Interactions, Hepatitis, Viral, Human, Humans, Narcotics, Prisoners, Antipsychotic Agents, Tuberculosis, HIV Infections, Comorbidity, AIDS-Related Opportunistic Infections, Evidence-Based Medicine, Anti-HIV Agents, Substance-Related Disorders, Drug Resistance, Bacterial, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. https://app.cochat.ai/papers/10.1016/s0140-6736(10)60829-x
The paper
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet. https://doi.org/10.1016/s0140-6736(10)60829-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.